Pegylation of Biological Molecules and Potential Benefits: Pharmacological Properties of Certolizumab Pegol
出版年份 2014 全文链接
标题
Pegylation of Biological Molecules and Potential Benefits: Pharmacological Properties of Certolizumab Pegol
作者
关键词
Rheumatoid Arthritis, Infliximab, Etanercept, Adalimumab, Certolizumab Pegol
出版物
BIODRUGS
Volume 28, Issue S1, Pages 15-23
出版商
Springer Nature
发表日期
2014-03-31
DOI
10.1007/s40259-013-0064-z
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- SAT0479 Clinical impact of immunogenicity of infliximab, adalimumab and etanercept: A systematic review of the literature with a meta-analysis
- (2014) S. Garcês et al. ANNALS OF THE RHEUMATIC DISEASES
- Immunogenicity of anti-TNF biologic therapies for rheumatoid arthritis
- (2013) Pauline A. van Schouwenburg et al. Nature Reviews Rheumatology
- The Immunogenicity of Polyethylene Glycol: Facts and Fiction
- (2013) Huub Schellekens et al. PHARMACEUTICAL RESEARCH
- Influence of immunogenicity on the efficacy of longterm treatment of spondyloarthritis with infliximab
- (2012) Chamaida Plasencia et al. ANNALS OF THE RHEUMATIC DISEASES
- Antidrug antibodies (ADAb) to tumour necrosis factor (TNF)-specific neutralising agents in chronic inflammatory diseases: a real issue, a clinical perspective
- (2012) Fabien B Vincent et al. ANNALS OF THE RHEUMATIC DISEASES
- Methotrexate reduces immunogenicity in adalimumab treated rheumatoid arthritis patients in a dose dependent manner
- (2012) Charlotte L Krieckaert et al. ANNALS OF THE RHEUMATIC DISEASES
- Size-dependent induction of accelerated blood clearance phenomenon by repeated injections of polymeric micelles
- (2012) Hiroyuki Koide et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Improved Health-related Quality of Life and Physical Function in Patients with Refractory Chronic Gout Following Treatment with Pegloticase: Evidence from Phase III Randomized Controlled Trials
- (2012) VIBEKE STRAND et al. JOURNAL OF RHEUMATOLOGY
- Anti-interferon-α neutralizing antibody is associated with nonresponse to pegylated interferon-α plus ribavirin in chronic hepatitis C
- (2012) F. Matsuda et al. JOURNAL OF VIRAL HEPATITIS
- Impact of Large Aggregated Uricases and PEG Diol on Accelerated Blood Clearance of PEGylated Canine Uricase
- (2012) Chun Zhang et al. PLoS One
- State of the art in PEGylation: The great versatility achieved after forty years of research
- (2011) Gianfranco Pasut et al. JOURNAL OF CONTROLLED RELEASE
- Certolizumab Pegol
- (2010) Niti Goel et al. mAbs
- Strategies to Extend Plasma Half-Lives of Recombinant Antibodies
- (2009) Roland E. Kontermann BIODRUGS
- A Pharmacodynamic Markov Mixed-Effects Model for Determining the Effect of Exposure to Certolizumab Pegol on the ACR20 Score in Patients With Rheumatoid Arthritis
- (2009) B D Lacroix et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Use of biofluorescence imaging to compare the distribution of certolizumab pegol, adalimumab, and infliximab in the inflamed paws of mice with collagen-induced arthritis
- (2009) Roger Palframan et al. JOURNAL OF IMMUNOLOGICAL METHODS
- A New PEG−β-Alanine Active Derivative for Releasable Protein Conjugation
- (2008) Gianfranco Pasut et al. BIOCONJUGATE CHEMISTRY
- A PEGylated Fab′ Fragment against Tumor Necrosis Factor for the Treatment of Crohn Disease
- (2008) Tim Bourne et al. BIODRUGS
- The Impact of PEGylation on Biological Therapies
- (2008) Francesco M Veronese et al. BIODRUGS
- The Pharmacology of PEGylation: Balancing PD with PK to Generate Novel Therapeutics
- (2008) C.Simone Fishburn JOURNAL OF PHARMACEUTICAL SCIENCES
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now